398.3K
Downloads
286
Episodes
We are a global law firm with a long-standing track record of successfully supporting the world’s leading national and multinational corporations, financial institutions and governments on ground-breaking and business-critical mandates.
Episodes
Thursday Mar 24, 2022
Thursday Mar 24, 2022
Licensing and collaboration agreements, integral to the life sciences and tech industries, are increasingly complex from an antitrust perspective.
First in a two-part series covering the regulatory landscape in innovation-driven industries, in this episode of the Essential Antitrust podcast our host Meghan Rissmiller is joined by Tone Oeyen, partner in Brussels, Jenny Leahy, senior associate in London and Kristen Riemenschneider, partner in Washington DC to discuss the cross-border regulatory considerations that arise throughout the lifespan of licensing and collaboration agreements.
No comments yet. Be the first to say something!